Participation of Dr. Martha Patricia Romero Mendoza, Researcher at the José Ramón de la Fuente Muñiz National Institute of Psychiatry in the X Action Research Forum on Drug Consumption Prevention on October 29, 2021
There is increasing evidence that the life-course origins of health and development begin before conception. We examined associations between timing and frequency of preconception cannabis and tobacco use and next generation...
The WHO Expert Committee on Drug Dependence defines treatment as the process that begins when psychoactive substance users contact a health provider or other community service and may continue through a succession of specific interventions...
Speaker: Dr. Silvia Morales Chainé
Academic session held on Monday, November 8, 2021.
The slides used by Dr. Morales Chainé are available at ISSUP: https://www.issup.net/node/15736
For more publications...
The report provides a regional analysis of the key trends and emerging developments of the synthetic drugs and NPS market as well as options for response in Latin America and the Caribbean.
Over the past years, the synthetics drug market...
The Canadian Centre on Substance Use and Addiction (CCSA) provided funding to Dr. Akwasi Owusu-Bempah and Dr. Scot Wortley from the University of Toronto to research youth interactions with the criminal justice system, including the nature...
The World Health Organization’s Less Alcohol Unit, Department of Health Promotion, the Alcohol Research Group, and the Alliance for Health Policy and Systems Research are pleased to announce a new scientific research and writing mentorship...
This seminar took place on Wednesday 29th September and focuses on youth justice.
It was the first in a series of seminars hosted by The University of Sydney after signing a Memorandum of Understanding with Youth Justice NSW in July 2021...
Presenters:
Elizabeth Saenz, UNODC, presents on the issue of patient abuse and corruption in treatment and provides a call to action on the need to address this problem that spans across countries.
This webinar highlighted the evidence base underpinning drug and alcohol residential rehabilitation and discussed future research directions.
Residential rehabilitation provides an important role in alcohol and other drug treatment. The...
This webinar looked at the reasons why the integration of AOD and mental health sectors has failed and outlines possible alternatives.
It almost goes without saying that addressing co-occurring alcohol and other drug and mental health...
This webinar explored the issues of infants withdrawing from maternal drugs of addiction, and problems beyond the newborn period.
Newborn drug withdrawal is often attributed to maternal opioids, but many other drugs can cause serious...
Opioid use disorder (OUD) and opioid overdose deaths (OODs) are prevalent among US workers, but work-related factors have not received adequate attention as either risk factors or opportunities for OOD prevention. Higher prevalence of OOD...
The Substance Abuse and Mental Health Services Administration (SAMHSA) has identified many well-researched drug-free workplace programs and published "A Kit for Employers: Making the workplace drug free".
This Employer kit describes the...
